Cone beam imaging, a new stroke imaging technology was showcased at the Society of NeuroInterventional Surgery’s (SNIS) 15th Annual Meeting in a presented study which aims at preventing nearly an hour of delay in patient care, providing them with the prospect of complete recovery.
Healthy.io, of Israel, gains FDA 510(k) approval for Dip.io, it's domestic urinalysis kit that transforms a smartphone into a clinical-standard diagnostic machine. It is the first and only smartphone-based urine analysis to be cleared as a Class 2 device.
23andMe declared an investment of $300 million on Wednesday, made by GlaxoSmithKline to attain special access to their DNA database.
A 20 percent to 50 percent higher risk of developing endometriosis in women with a past of sexual or emotional abuse was observed by a European study published in the journal, Human Reproduction. Similarly, a large U.S. study in the same journal yielded matching results with sexual or physical abuse in the past.
Siemens Health received US-FDA (US-Food and Drug Administration) clearance for two highly sensitive troponin assays, which detect protein levels released into the bloodstream during a heart attack allowing them to be made available in the U.S.
On 26 July 2018, Omeros Corporation announced that the European Medicines Agency's (EMA's) Committee for Orphan Medicinal Products (COMP) have positively recommended the lead human monoclonal antibody named OMS721 for stem cell transplantation therapy.
Around 54 million to 60 million people throughout the world are annually surviving with Traumatic Brain Injury annually. CT scan tests of the head are the common diagnostic choices in such cases. This extensive use of CT scans leads to unnecessary radiation exposure with high costs.
Stiff skin syndrome causes a person's skin to harden and thicken across the entire body. This thickening results in a person being unable to move his or her joints, leaving the joints stuck in a bent position. The genetic disorder affects the protein named fibrillin-1, which allows the elastic fibers in the skin to stretch.
96-week data on doravirine, Merck’s HIV drug, was posted by the drugmaker recently. Merck expects it to outrun drugs like Bristol-Myers Squibb’s Sustiva in combination regimens and antiretroviral drugs from AbbVie and Johnson & Johnson in viral suppression.
Lawson Health Research Institute, Memorial Sloan Kettering Cancer Center, the Royal Marsden and Epic Sciences conducted an international mutual study which discovered a novel blood test that can foresee advanced prostate cancer patient response to particular treatments, resulting in better survival.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.